Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Debt to Equity (2022 - 2025)

Historic Debt to Equity for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $0.32.

  • Orchestra BioMed Holdings' Debt to Equity changed N/A to $0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.32, marking a year-over-year change of. This contributed to the annual value of $0.43 for FY2024, which is N/A changed from last year.
  • Orchestra BioMed Holdings' Debt to Equity amounted to $0.32 in Q3 2025.
  • Orchestra BioMed Holdings' Debt to Equity's 5-year high stood at $48.76 during Q2 2025, with a 5-year trough of $0.1 in Q1 2023.
  • Moreover, its 4-year median value for Debt to Equity was $0.27 (2022), whereas its average is $6.36.